| For: | Takedatsu H, Mitsuyama K, Torimura T. Nanomedicine and drug delivery strategies for treatment of inflammatory bowel disease. World J Gastroenterol 2015; 21(40): 11343-11352 [PMID: 26525603 DOI: 10.3748/wjg.v21.i40.11343] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i40/11343.htm |
| Number | Citing Articles |
| 1 |
Maricla Galetti, Stefano Rossi, Cristina Caffarra, Amparo Guerrero Gerboles, Michele Miragoli. Exposure to Engineered Nanomaterials in the Environment. 2019; doi: 10.1016/B978-0-12-814835-8.00009-1
|
| 2 |
Daniela Placha, Josef Jampilek. Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems. Pharmaceutics 2021; 13(1) doi: 10.3390/pharmaceutics13010064
|
| 3 |
Bojan Čalija, Jela Milić. Targeted delivery of anti-inflammatory drugs in lower parts of gastrointestinal tract: Conventional and novel approaches. Arhiv za farmaciju 2017; 67(3) doi: 10.5937/arhfarm1702124C
|
| 4 |
Mohammad Samimi Tanoorjeh, Hossein Shahdadi Sardou, Sara Feizollahi, Prashant Kesharwani, Mohammadreza Abbaspour, Amirhossein Sahebkar. Targeting mitochondrial dysfunction through nanomedicine: a new avenue for inflammatory bowel disease therapy. Microchemical Journal 2026; 224 doi: 10.1016/j.microc.2026.117838
|
| 5 |
Lauren J. Mohan, Jacqueline S. Daly, Barbara M. Ryan, Zebunnissa Ramtoola. The future of nanomedicine in optimising the treatment of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2019; 54(1) doi: 10.1080/00365521.2018.1563805
|
| 6 |
Chenxi Huang, Jian Xu, Jing Li, Siyu He, Huipeng Xu, Xiaohong Ren, Vikramjeet Singh, Li Wu, Jiwen Zhang. Hydrogen peroxide responsive covalent cyclodextrin framework for targeted therapy of inflammatory bowel disease. Carbohydrate Polymers 2022; 285 doi: 10.1016/j.carbpol.2022.119252
|
| 7 |
Ying Cai, Luoxin Zhang, Youjian Zhang, Rong Lu. Plant-Derived Exosomes as a Drug-Delivery Approach for the Treatment of Inflammatory Bowel Disease and Colitis-Associated Cancer. Pharmaceutics 2022; 14(4) doi: 10.3390/pharmaceutics14040822
|
| 8 |
Tamara G. Dacoba, Ana Olivera, Dolores Torres, José Crecente-Campo, María José Alonso. Modulating the immune system through nanotechnology. Seminars in Immunology 2017; 34 doi: 10.1016/j.smim.2017.09.007
|
| 9 |
Hong Yang, Lisa Kozicky, Aabida Saferali, Shan-Yu Fung, Nicole Afacan, Bing Cai, Reza Falsafi, Erin Gill, Mingyao Liu, Tobias R. Kollmann, R.E.W. Hancock, Laura M. Sly, Stuart E. Turvey. Endosomal pH modulation by peptide-gold nanoparticle hybrids enables potent anti-inflammatory activity in phagocytic immune cells. Biomaterials 2016; 111 doi: 10.1016/j.biomaterials.2016.09.032
|
| 10 |
MARIA MEMECICĂ, ANA-MARIA ALBU , NATALIA SIMIONESCU , DAMIEN CHAUDANSON , ALIN IONUȚ ALECU . FRESHWATER CRAYFISH CHITOSAN – A NOVEL SOURCE FOR NANOPARTICLE DEVELOPMENT: OPTIMIZATION, CHEMICAL MODIFICATIONS AND CHARACTERIZATION. Cellulose Chemistry and Technology 2025; 59(7-8) doi: 10.35812/CelluloseChemTechnol.2025.59.65
|
| 11 |
Chau T. H. Nguyen, Richard I. Webb, Lynette K. Lambert, Ekaterina Strounina, Edward C. Lee, Marie-Odile Parat, Michael A. McGuckin, Amirali Popat, Peter J. Cabot, Benjamin P. Ross. Bifunctional Succinylated ε-Polylysine-Coated Mesoporous Silica Nanoparticles for pH-Responsive and Intracellular Drug Delivery Targeting the Colon. ACS Applied Materials & Interfaces 2017; 9(11) doi: 10.1021/acsami.7b00411
|
| 12 |
Quanquan Zhou, Ge‑Lin Zhang, Weitong Sun, Jiayi Cai, Li-Hua Yu. Nanomaterials and exercise interventions: A synergistic approach for atherosclerosis therapy (Review). International Journal of Molecular Medicine 2025; 57(2) doi: 10.3892/ijmm.2025.5715
|
| 13 |
Andreea Nedelcu, Ofelia Mosteanu, Teodora Pop, Teodora Mocan, Lucian Mocan. Recent Advances in Nanoparticle-Mediated Treatment of Inflammatory Bowel Diseases. Applied Sciences 2021; 11(1) doi: 10.3390/app11010438
|
| 14 |
Chandrashekhar Jori, Anis Ahmad Chaudhary, Summya Rashid, Mohamed A. M. Ali, Abdullah S. Alawam, Faouzi Haouala, Rehan Khan. Biomaterial-based strategies for immunomodulation in IBD: current and future scenarios. Journal of Materials Chemistry B 2023; 11(25) doi: 10.1039/D3TB00276D
|
| 15 |
Chengcheng Gao, Zerun Yang, Ruirui Song, Huagang Sheng, Liqiao Zhu. Nanotechnology-based drug delivery system for targeted therapy of ulcerative colitis from traditional Chinese medicine: A review. International Journal of Pharmaceutics 2025; 673 doi: 10.1016/j.ijpharm.2025.125375
|
| 16 |
Joseph Laubach, Rajesh K. Sani. Natural Biopolymers for Drug Delivery. 2025; doi: 10.1016/B978-0-323-95367-2.00006-5
|
| 17 |
Junzu Shi, Danyang Cui, Li Yu, Yang Gong. Structural and temporal dynamics of nano-based therapies in ulcerative colitis: history, hotspots, and emerging trends. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1739037
|
| 18 |
Chao Ji, Wei Li. Chemical Characterization and Green Formulation of Silver Nanoparticles by Trachyspermum copticum L for the Treatment of Dextran Sulfate Sodium‐Induced Acute Enteritis in Sprague–Dawley Rats. Applied Organometallic Chemistry 2025; 39(4) doi: 10.1002/aoc.70097
|
| 19 |
Yu Zhang, Zhiqiang Zhang, Zhang Qin, Mika Sillanpää. Prevention of dextran sulfate sodium-induced acute enteritis by zinc nanoparticles green-formulated by sodium lignosulfonate. Inorganic Chemistry Communications 2024; 168 doi: 10.1016/j.inoche.2024.112844
|
| 20 |
Hong-Yu Jiang, Bo Shao, Hong-Da Wang, Wen-Qi Zhao, Shao-Hua Ren, Yi-Ni Xu, Tong Liu, Cheng-Lu Sun, Yi-Yi Xiao, Yi-Cheng Li, Qiang Chen, Peng-Yu Zhao, Guang-Mei Yang, Xu Liu, Yu-Fan Ren, Hao Wang. Analysis of nanomedicine applications for inflammatory bowel disease: structural and temporal dynamics, research hotspots, and emerging trends. Frontiers in Pharmacology 2025; 15 doi: 10.3389/fphar.2024.1523052
|
| 21 |
Vincent Lenders, Xanthippi Koutsoumpou, Philana Phan, Stefaan J. Soenen, Karel Allegaert, Steven de Vleeschouwer, Jaan Toelen, Zongmin Zhao, Bella B. Manshian. Modulation of engineered nanomaterial interactions with organ barriers for enhanced drug transport. Chemical Society Reviews 2023; 52(14) doi: 10.1039/D1CS00574J
|
| 22 |
Loredana Serpe, Roberto Canaparo, Carlo Della Pepa, Paolo Gasco, Elisabetta Muntoni, Arianna Carolina Rosa, Benedetta Ferrara, Federica Foglietta, Chiara Dianzani. Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an <i>in vivo</i> model. World Journal of Gastroenterology 2017; 23(23): 4200-4210 doi: 10.3748/wjg.v23.i23.4200
|
| 23 |
Runxin Xu, Marie-Christin Weber, Xinkai Hu, Philipp-Alexander Neumann, Nazila Kamaly. Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy. Seminars in Immunology 2022; doi: 10.1016/j.smim.2022.101664
|
| 24 |
Cintia M. S. Cereda, Giovana R. Tofoli. Biotechnology Applied to Inflammatory Diseases. Interdisciplinary Biotechnological Advances 2023; doi: 10.1007/978-981-19-8342-9_13
|
| 25 |
Qing Li, Ying Liu, Xianglin Dai, Wei Jiang, Huan Zhao. Nanozymes Regulate Redox Homeostasis in ROS-Related Inflammation. Frontiers in Chemistry 2021; 9 doi: 10.3389/fchem.2021.740607
|
| 26 |
Anuj Kumar Mehta, Roshani Kumari Sah, Abhishesh Kumar Mehata, Deepa Dehari. Nano-Bio-Medicine for Gastrointestinal Diseases. 2026; doi: 10.1016/B978-0-443-34039-0.00004-4
|
| 27 |
Jorge O. Avila-Alejo, Ana K. González-Palomo, Germán Plascencia-Villa, Miguel José-Yacamán, Hugo R. Navarro-Contreras, Iván N. Pérez-Maldonado. Low cytotoxicity of anisotropic gold nanoparticles coated with lysine on peripheral blood mononuclear cells “in vitro”. Environmental Toxicology and Pharmacology 2017; 56 doi: 10.1016/j.etap.2017.09.014
|
| 28 |
Rohitas Deshmukh, Ranjit K. Harwansh, Swarnali Das Paul, Rishikesh Shukla. Controlled release of sulfasalazine loaded amidated pectin microparticles through Eudragit S 100 coated capsule for management of inflammatory bowel disease. Journal of Drug Delivery Science and Technology 2020; 55 doi: 10.1016/j.jddst.2019.101495
|
| 29 |
Xiaoxian Wang, Si Li, Xin Liu, Xian Wu, Ningbing Ye, Xiangliang Yang, Zifu Li. Bio-Nanomedicine for Cancer Therapy. Advances in Experimental Medicine and Biology 2021; 1295 doi: 10.1007/978-3-030-58174-9_4
|
| 30 |
Haiming Chen, Waliul Islam, Jessica El Halabi, Ling Li, Florin M. Selaru. Innovative Gastrointestinal Drug Delivery Systems: Nanoparticles, Hydrogels, and Microgrippers. Frontiers in Bioscience-Landmark 2025; 30(2) doi: 10.31083/FBL25281
|
| 31 |
Amandeep Singh, Kirandeep Kaur, Uttam Kumar Mandal, Raj Kumar Narang. Nanoparticles as Budding Trends in Colon Drug Delivery for the Management of Ulcerative Colitis. Current Nanomedicine 2020; 10(3) doi: 10.2174/2468187310999200621200615
|
| 32 |
Murtada A. Oshi. Inflammatory bowel disease in Africa: the current landscape of pharmacological treatments and the promise of emerging innovations. Exploration of Drug Science 2025; 3 doi: 10.37349/eds.2025.1008117
|
| 33 |
Fanny Giron, Anna Pastó, Ennio Tasciotti, Bincy P Abraham. Nanotechnology in the Treatment of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019; 25(12) doi: 10.1093/ibd/izz205
|
| 34 |
Chanchan Qiao, Xinru Yuan, Ting Li, Tiantian Song, Ying Ling, Yunzhao Chui, Xiao Song. Targeting the pathological microenvironment of ulcerative colitis: Recent advances in self-assembled nanosystems. Journal of Drug Delivery Science and Technology 2026; 126 doi: 10.1016/j.jddst.2026.108779
|
| 35 |
Markus Ries, Brice Moulari, Maryam A. Shetab Boushehri, Mohamed Ehab Ali, Daniel Molnar, Arnaud Béduneau, Yann Pellequer, Alf Lamprecht. Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting. Pharmaceutics 2022; 14(2) doi: 10.3390/pharmaceutics14020352
|
| 36 |
Deenaz Zaidi, Eytan Wine. Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases. Frontiers in Pediatrics 2018; 6 doi: 10.3389/fped.2018.00317
|
| 37 |
Bom Lee, Jeeeun Yoo, Han Sol Lee, Yonghyun Lee. Targeted-Immunomodulatory Nanomedicines for the Treatment of Autoimmune Diseases via Multiple Administration Routes. International Journal of Nanomedicine 2025; doi: 10.2147/IJN.S558540
|
| 38 |
Meng Yan, Li Zhu, Shuai Wu, Yu Cao, Nianlian Mou, Qingjia Chi, Guixue Wang, Yuan Zhong, Wei Wu. ROS responsive polydopamine nanoparticles to relieve oxidative stress and inflammation for ameliorating acute inflammatory bowel. Biomaterials Advances 2022; 142 doi: 10.1016/j.bioadv.2022.213126
|
| 39 |
|
| 40 |
Jinlin Liu, Yanxia Chen, Dongsheng Liu, Wei Liu, Sijun Hu, Nanjin Zhou, Yong Xie. Ectopic expression of SIGIRR in the colon ameliorates colitis in mice by downregulating TLR4/NF-κB overactivation. Immunology Letters 2017; 183 doi: 10.1016/j.imlet.2017.01.015
|
| 41 |
Yilin Guo, Shiyu Zong, Yiqiong Pu, Benliang Xu, Tong Zhang, Bing Wang. Advances in Pharmaceutical Strategies Enhancing the Efficiencies of Oral Colon-Targeted Delivery Systems in Inflammatory Bowel Disease. Molecules 2018; 23(7) doi: 10.3390/molecules23071622
|
| 42 |
Ruifeng Luo, Meisi Lin, Chen Zhang, Jinfeng Shi, Siyuan Zhang, Qiyan Chen, Yichen Hu, Minyue Zhang, Jinming Zhang, Fei Gao. Genipin-crosslinked human serum albumin coating using a tannic acid layer for enhanced oral administration of curcumin in the treatment of ulcerative colitis. Food Chemistry 2020; 330 doi: 10.1016/j.foodchem.2020.127241
|
| 43 |
Tolulope O. Ajala, Abraham Abraham, Cornelia M. Keck, Oluwatoyin A. Odeku, Taiwo O. Elufioye, James O. Olopade. Shea butter (Vitellaria paradoxa) and Pentaclethra macrophylla oil as lipids in the formulation of Nanostructured lipid carriers. Scientific African 2021; 13 doi: 10.1016/j.sciaf.2021.e00965
|
| 44 |
Jingjing Jiang, Jingcheng Xiao, Zexu Zhao, Mao-Sen Yuan, Jinyi Wang. One-step prepared nano-in-micro microcapsule delivery vehicle with sequential burst–sustained drug release for the targeted treatment of inflammatory bowel disease. Materials Chemistry Frontiers 2021; 5(16) doi: 10.1039/D1QM00589H
|
| 45 |
Herve Courthion, Thibault Mugnier, Christel Rousseaux, Michael Möller, Robert Gurny, Doris Gabriel. Self-assembling polymeric nanocarriers to target inflammatory lesions in ulcerative colitis. Journal of Controlled Release 2018; 275 doi: 10.1016/j.jconrel.2017.07.044
|
| 46 |
Hisako Ibaraki, Naruhiro Hatakeyama, Naoki Arima, Akihiro Takeda, Yasuo Seta, Takanori Kanazawa. Systemic delivery of siRNA to the colon using peptide modified PEG-PCL polymer micelles for the treatment of ulcerative colitis. European Journal of Pharmaceutics and Biopharmaceutics 2022; 170 doi: 10.1016/j.ejpb.2021.12.009
|
| 47 |
Sufeng Zhang, Won Joon Cho, Amy T. Jin, Lie Yun Kok, Yunhua Shi, David E. Heller, Young‐Ah Lucy Lee, Yixuan Zhou, Xi Xie, Joshua R. Korzenik, Jochen K. Lennerz, Giovanni Traverso. Heparin‐Coated Albumin Nanoparticles for Drug Combination in Targeting Inflamed Intestine. Advanced Healthcare Materials 2020; 9(16) doi: 10.1002/adhm.202000536
|
| 48 |
Tamara Pérez-Jeldres, Christopher J Tyler, Joshua D Boyer, Thangaraj Karuppuchamy, Giorgos Bamias, Parambir S Dulai, Brigid S Boland, William J Sandborn, Derek R Patel, Jesús Rivera-Nieves. Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis Concepts. Inflammatory Bowel Diseases 2019; 25(2) doi: 10.1093/ibd/izy269
|
| 49 |
Sourav Bhattacharjee. DLS and zeta potential – What they are and what they are not?. Journal of Controlled Release 2016; 235 doi: 10.1016/j.jconrel.2016.06.017
|